The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats

European Journal of Pharmacology

Volumn 650, Issue 1, 2011, Pages 384-389

  Liu, Su ^a   Wu, Han Jun ^b   Zhang, Zong Qi ^c   Chen, Qing ^a   Liu, Bin ^a   Wu, Jian Ping ^a   Zhu, Liang ^b  

^a Zhabei District Central Hospital   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Adiponectin; Nonalcoholic steatohepatitis; Rats; Receptor; Rosiglitazone

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; BETA ACTIN; MESSENGER RNA; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HISTOPATHOLOGY; INTRAABDOMINAL FAT; LIPID DIET; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; TREATMENT DURATION; TREATMENT RESPONSE;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE EXPRESSION REGULATION; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADIPONECTIN; RNA, MESSENGER; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649741621     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.082     Document Type: Article

References (26)

1. T. Asano, K. Watanabe, N. Kubota, T. Gunji, M. Omata, T. Kadowaki, and S. Ohnishi Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis J. Gastroenterol. Hepatol. 24 2009 1669 1676
2. A.H. Berg, T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat. Med. 7 2001 947 953
3. G. Chinetti, C. Zawadski, J.C. Fruchart, and B. Staels Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR Biochem. Biophys. Res. Commun. 314 2004 151 158
4. T.P. Combs, U.B. Pajvani, A.H. Berg, Y. Lin, L.A. Jelicks, M. Laplante, A.R. Nawrocki, M.W. Rajala, A.F. Parlow, L. Cheeseboro, Y.Y. Ding, R.G. Russell, D. Lindemann, A. Hartley, G.R. Baker, S. Obici, Y. Deshaies, M. Ludgate, L. Rossetti, and P.E. Scherer A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity Endocrinology 145 2004 367 383
5. J. Fruebis, T.S. Tsao, S. Javorschi, D. Ebbets-Reed, M.R. Erickson, F.T. Yen, B.E. Bihain, and H.F. Lodish Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proc. Natl. Acad. Sci. U. S. A. 98 2001 2005 2010
6. S.A. Harrison, S. Kadakia, K.A. Lang, and S. Schenker Nonalcoholic steatohepatitis: what we know in the new millennium Am. J. Gastroenterol. 97 2002 2714 2724
7. F. Holguin, M. Rojas, and C.M. Hart The peroxisome proliferator activated receptor gamma (PPARgamma) ligand rosiglitazone modulates bronchoalveolar lavage levels of leptin, adiponectin, and inflammatory cytokines in lean and obese mice Lung 185 2007 367 372
8. S.G. Hubscher Histological assessment of non-alcoholic fatty liver disease Histopathology 49 2006 450 465
9. T. Kadowaki, and T. Yamauchi Adiponectin and adiponectin receptors Endocr. Rev. 26 2005 439 451
10. S. Kaser, A. Moschen, A. Cayon, A. Kaser, J. Crespo, F. Pons-Romero, C.F. Ebenbichler, J.R. Patsch, and H. Tilg Adiponectin and its receptors in non-alcoholic steatohepatitis Gut 54 2005 117 121 (Pubitemid 40007229)
11. C.Z. Larter, and G.C. Farrell Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat? J. Hepatol. 44 2006 253 261
12. H. Nakayama, S. Otabe, X. Yuan, T. Ueno, N. Hirota, T. Fukutani, N. Wada, T. Hashinaga, and K. Yamada Effects of adiponectin transgenic expression in liver of nonalcoholic steatohepatitis model mice Metabolism 58 2009 901 908
13. M. Nannipieri, F. Cecchetti, M. Anselmino, E. Mancini, G. Marchetti, A. Bonotti, S. Baldi, B. Solito, M. Giannetti, A. Pinchera, F. Santini, and E. Ferrannini Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis Obes. Surg. 19 2009 467 474
14. A.R. Nawrocki, M.W. Rajala, E. Tomas, U.B. Pajvani, A.K. Saha, M.E. Trumbauer, Z. Pang, A.S. Chen, N.B. Ruderman, H. Chen, L. Rossetti, and P.E. Scherer Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists J. Biol. Chem. 281 2006 2654 2660
15. N. Ouchi, S. Kihara, Y. Arita, M. Nishida, A. Matsuyama, Y. Okamoto, M. Ishigami, H. Kuriyama, K. Kishida, H. Nishizawa, K. Hotta, M. Muraguchi, Y. Ohmoto, S. Yamashita, T. Funahashi, and Y. Matsuzawa Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 103 2001 1057 1063
16. Y. Peng, D. Rideout, S. Rakita, M. Sajan, R. Farese, M. You, and M.M. Murr Downregulation of adiponectin/AdipoR2 is associated with steatohepatitis in obese mice J. Gastrointest. Surg. 13 2009 2043 2049
17. S.A. Polyzos, J. Kountouras, and C. Zavos Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis Hepatol. Res. 40 2010 446 447
18. P. Puri, M.M. Wiest, O. Cheung, F. Mirshahi, C. Sargeant, H.K. Min, M.J. Contos, R.K. Sterling, M. Fuchs, H. Zhou, S.M. Watkins, and A.J. Sanyal The plasma lipidomic signature of nonalcoholic steatohepatitis Hepatology 50 2009 1827 1838
19. V. Ratziu, P. Giral, S. Jacqueminet, F. Charlotte, A. Hartemann-Heurtier, L. Serfaty, P. Podevin, J.M. Lacorte, C. Bernhardt, E. Bruckert, A. Grimaldi, and T. Poynard Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial Gastroenterology 135 2008 100 110
20. Y.S. Seo, J.H. Kim, N.Y. Jo, K.M. Choi, S.H. Baik, J.J. Park, J.S. Kim, K.S. Byun, Y.T. Bak, C.H. Lee, A. Kim, and J.E. Yeon PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes J. Gastroenterol. Hepatol. 23 2008 102 109
21. M. Shimada, H. Kawahara, K. Ozaki, M. Fukura, H. Yano, M. Tsuchishima, M. Tsutsumi, and S. Takase Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7 S level to predict the early stage of nonalcoholic steatohepatitis Am. J. Gastroenterol. 102 2007 1931 1938
22. X. Sun, R. Han, Z. Wang, and Y. Chen Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone Diabetologia 49 2006 1303 1310
23. M. Uribe, D. Zamora-Valdes, M. Moreno-Portillo, L. Bermejo-Martinez, R. Pichardo-Bahena, H.A. Baptista-Gonzalez, G. Ponciano-Rodriguez, M.H. Uribe, R. Medina-Santillan, and N. Mendez-Sanchez Hepatic expression of ghrelin and adiponectin and their receptors in patients with nonalcoholic fatty liver disease Ann. Hepatol. 7 2008 67 71
24. T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, Nh. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, and T. Kadowaki Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 2003 762 769
25. J.M. Ye, P.J. Doyle, M.A. Iglesias, D.G. Watson, G.J. Cooney, and E.W. Kraegen Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation Diabetes 50 2001 411 417
26. T. Yokota, K. Oritani, I. Takahashi, J. Ishikawa, A. Matsuyama, N. Ouchi, S. Kihara, T. Funahashi, A.J. Tenner, Y. Tomiyama, and Y. Matsuzawa Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages Blood 96 2000 1723 1732